Studies of α-granule proteins in cultured human megakaryocytes

Thrombosis and Haemostasis

Volumn 90, Issue 5, 2003, Pages 844-852

  Veljkovic, Dragoslava Kika ^a,b   Cramer, Elisabeth M ^a,b   Alimardani, Gulie ^a,b   Fichelson, Serge ^a,b   Massé, Jean Marc ^a,b   Hayward, Catherine P M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Hôpital de Port Royal ^*  (France)

Author keywords

Megakaryocytes; Platelets; Protein processing; granules

Indexed keywords

ALPHA GRANULE PROTEIN; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR 5; FIBRINOGEN; GLYCOPROTEIN; HEPARIN; MULTIMERIN; PROTEIN; THROMBOCYTE FACTOR 4; THROMBOPOIETIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; MEGAKARYOCYTE; PRIORITY JOURNAL; THROMBOCYTE; UMBILICAL CORD BLOOD;

EID: 0242606430     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-02-0125     Document Type: Article

References (40)

1. Burgess TL, Kelly RB. Constitutive and regulated secretion of proteins. Ann Rev Cell Biol 1987; 3: 243-93.
2. Reed GL: Platelet secretion. In: Platelets. Academic Press 2002; 181-95.
3. Cramer EM, Masse JM, Caen JP, et al. Effect of thrombin on maturing human megakaryocytes. Am J Pathol 1993; 143: 1498-1508.
4. Cramer EM. Platelets and megakaryocytes: Anatomy and structural organization. In: Hemostasis and Thrombosis: Basic Principles and Practice. Lippincott Williams and Wilkins, 2001; 411-428.
5. Hayward CPM, Warkentin TE, Horsewood P, et al.. Multimerin: A series of large disulfide-linked multimeric proteins within platelets. Blood 1991; 77: 2556-60.
6. Hayward CPM. Inherited disorders of platelet α-granules. Platelets 1997; 8: 197-210.
7. Hayward CPM, Weiss HJ, Lages B, et al. The storage defects in grey platelet syndrome and αδ-storage pool deficiency affect α-granule factor V and multimerin storage without altering their proteolytic processing. Br J Haematol 2001; 113: 871-7.
8. Drouin A, Favier R, Masse JM, et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001; 98: 1382-391.
9. Cramer EM, Norol F, Guichard J, et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 1997; 89: 2336-46.
10. Hayward CPM, Bainton DF, Smith JW, et al. Multimerin is found in the ?-granules of resting platelets and is synthesized by a megakaryocytic cell line. J Clin Invest 1993; 91: 2630-9.
11. Hayward CPM, Cramer EM, Song Z, et al. Studies of multimerin in human endothelial cells. Blood 1998; 91: 1304-17.
12. Hayward CPM, Song Z, Zheng S, et al. Multimerin processing by cells with and without pathways for regulated protein secretion. Blood 1999; 94: 1337-47.
13. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986; 46: 185-90.
14. Rosnoblet C, Ribba AS, Wollheim CB, et al. Regulated von Willebrand factor (VWF) secretion is restored by pro-VWF expression in a transfectable endothelial cell line. Biochim Biophys Acta 2000; 1495: 112-9.
15. Koedam JA, Cramer EM, Briend E, et al. P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in At-T-20 cells. J Cell Biol 1992; 116: 617-25.
16. Disdier M, Morrissey JH, Fugate RD, et al.. Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell 1992; 3: 309-21.
17. Norcott JP, Solari R, Cutler DF. Targeting of P-selectin to two regulated secretory organelles in PC12 cells. J Cell Biol 1996; 134: 1229-40.
18. Gombau L, Schleef RR. Processing of type 1 plasminogen activator inhibitor (PAI-1) into the regulated secretory pathway. J Biol Chem 1994; 269: 3875-80.
19. Choi ES, Nichol JL, Hokom MM, et al.. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995; 85: 402-13.
20. Mattia G, Vulcano F, Milazzo L, et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 2002; 99: 888-97.
21. Norol F, Vitrat N, Cramer E, et al. Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood 1998; 91: 830-43.
22. Hayward CPM, Rivard GE, Kane WH, et al. An autosomal dominant qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996; 87: 4967-78.
23. Fichelson S, Freyssinier JM, Picard F, et al. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood 1999; 94: 1601-13.
24. Zauli G, Vitale M, Falcieri E, et al. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood 1997; 90: 2234-43.
25. Kahr WA, Zheng S, Sheth PM, et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001; 98: 257-65.
26. Chen CI, Federici AB, Cramer EM, et al. Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency. Br J Haematol 1998; 103: 20-8.
27. Cramer EM, Debili N, Martin JF, et al. Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes. Blood 1989; 73: 1123-9.
28. Fleming JC, Berger C, Guichard J, et al. The transmembrane domain enhances granular targeting of P-selectin. Eur J Cell Biol 1998; 75: 331-43.
29. Schipper LF, Brand A, Reniers N, et al. Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol 2003; 31: 324-30.
30. Cramer EM, Meyer D, Le Menn R, et al. Eccentric localization of von Willebrand factor in an internal structure of platelet α-granule resembling that of Weibel-Palade bodies. Blood 1985; 66: 710-3.
31. Zhang C, Thronton MA, Kowalska A, et al. Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus. Blood 2001; 98: 610-7.
32. Sporn LA, Chavin SI, Marder VJ, et al. Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest 1985; 76: 1102-6.
33. Hayward CPM, Smith JW, Horsewood P, et al. p-155, a multimerin platelet protein that is expressed on activated platelets. J Biol Chem 1991; 266: 7114-20.
34. Sadler JE. Biochemistry and genetics of von Willebrand factor. Ann Rev Biochem 1998; 67: 395-424.
35. Bergeron F, Leduc R, Day R. Subtilase-like pro-protein convertases: From molecular specificity to therapeutic applications. J Mol Endocrinol 2000; 24: 1-22.
36. Chiu HC, Schick PK, Colman RW. Bio-synthesis of factor V in isolated guinea pig megakaryocytes. J Clin Invest 1985; 75: 339-46.
37. Gewirtz AM, Shapiro C, Shen YM, et al. Cellular and molecular regulation of factor V expression in human megakaryocytes. J Cell Physiol 1992; 153: 277-87.
38. Sun H, Yang TL, Yang A, et al. The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis. Blood 2003; 102: 2856-64.
39. Camire RM, Pollak ES, Kaushansky K, et al. Secretable human platelet-derived factor V originates from the plasma pool. Blood 1998; 92: 3035-41.
40. Gebrane-Younes J, Cramer EM, Orcel L, et al. Gray platelet syndrome: Dissociation between abnormal sorting in megakaryocyte α-granules and normal sorting in Weibel-Palade bodies of endothelial cells. J Clin Invest 1993; 92: 3023-8.